Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call Transcript August 12, 2024

Biora Therapeutics, Inc. beats earnings expectations. Reported EPS is $9.0E-5, expectations were $-0.45.

Operator: Welcome to the Biora Therapeutics Second Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I will now...